
Deepak Mohan
About Deepak Mohan
Data last updated:
Deepak Mohan is a Managing Director at Group Pharmaceuticals Limited (since 2024), Director at Covestays Private Limited (since 2019) and Designated Partner at Mape Pharmascience Llp (since 2024), and holds 5 more current directorships. The companies operate in Pharma, Real Estate and Construction and Real Estate. The 3 current companies with reported revenue have a combined latest revenue of ₹173 Cr; the largest is Group Pharmaceuticals Limited at ₹168 Cr (FY 2025). Earlier, Deepak Mohan was a Director at R.L.Fine Chem Private Limited (2018–2021) and Whole-Time Director at Vitalcore Industrials Private Limited (2020–2022) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 24 May 2024 | 1980 | ₹168 Cr (FY 2025) | Active | |
| Director | 15 Oct 2019 | 2018 | ₹4.82 Cr (FY 2025) | Active | |
| Designated Partner | 22 Jul 2024 | 2016 | ₹1.5 Lakh (FY 2023) | Active | |
| Designated Partner | 04 Sep 2024 | 2024 | Active | ||
| Designated Partner | 09 Oct 2023 | 2023 | Active | ||
| Designated Partner | 27 Dec 2022 | 2022 | Active | ||
| Designated Partner | 16 Mar 2021 | 2021 | Active | ||
| Designated Partner | 02 Mar 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Feb 2018 | 2011 | ₹360 Cr (FY 2025) | Active | |
| Whole-Time Director | 11 Dec 2020 | 2017 | ₹27.40 Cr (FY 2025) | Active | |
| Director | 24 Dec 2020 | 2020 | ₹4.29 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Deepak Mohan
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Deepak Mohan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deepak Mohan
Deepak Mohan currently holds 8 directorships: Group Pharmaceuticals Limited (Managing Director, since 24 May 2024, revenue ₹168 Cr (FY 2025)); Covestays Private Limited (Director, since 15 Oct 2019, revenue ₹4.82 Cr (FY 2025)); Mape Pharmascience Llp (Designated Partner, since 22 Jul 2024, revenue ₹1.5 Lakh (FY 2023)); Cove Offices Metro Llp (Designated Partner, since 04 Sep 2024); Cove Offices Omr Llp (Designated Partner, since 09 Oct 2023); and 3 more.
Deepak Mohan was first appointed on 05 Feb 2018 as Director at R.L.Fine Chem Private Limited. The most recent appointment on record is 04 Sep 2024 at Cove Offices Metro Llp.
The 3 current companies of Deepak Mohan that report revenue have a combined latest revenue of ₹173 Cr: Group Pharmaceuticals Limited ₹168 Cr (FY 2025); Covestays Private Limited ₹4.82 Cr (FY 2025); Mape Pharmascience Llp ₹1.5 Lakh (FY 2023).
Deepak Mohan held 3 earlier board appointments: R.L.Fine Chem Private Limited (Director, 05 Feb 2018 to 11 Aug 2021); Vitalcore Industrials Private Limited (Whole-Time Director, 11 Dec 2020 to 01 Oct 2022); Vitalcore Technologies Private Limited (Director, 24 Dec 2020 to 30 Jun 2022).
The current boards of Deepak Mohan's companies include Ann Valerie Sunil Attavar (Group Pharmaceuticals Limited), Jacob Mathew (Group Pharmaceuticals Limited), Nandipur Kallappa Dilip (Group Pharmaceuticals Limited), Nikhil Kaushik (Group Pharmaceuticals Limited), Nikhil Kaushik (Group Pharmaceuticals Limited), Srinivas Gogineni (Group Pharmaceuticals Limited), among others.